• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化家族性癌症风险:临床肿瘤学家的资源。

Quantitating familial cancer risk: a resource for clinical oncologists.

作者信息

Offit K, Brown K

机构信息

Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY.

出版信息

J Clin Oncol. 1994 Aug;12(8):1724-36. doi: 10.1200/JCO.1994.12.8.1724.

DOI:10.1200/JCO.1994.12.8.1724
PMID:8040684
Abstract

PURPOSE

Because a family history of cancer constitutes an important risk factor, estimation and communication of cancer risk can facilitate efforts toward early detection and prevention. This review provides a resource for health professionals called to draw upon a multidisciplinary literature to provide quantitative risk estimates to families with cancer.

DESIGN

Descriptive population-derived, epidemiologic, genetic, genetic epidemiologic, and molecular studies are critically reviewed in the context of cancer genetic counseling.

RESULTS

Data are presented that document the increased lifetime relative risk to relatives of individuals with cancers of the breast, ovary, colon, prostate, or other sites. In general, risk ratios are poorly suited for clinical counseling. Age-specific absolute risks are presented for first-degree relatives of individuals affected by cancers of the breast, ovary, and colon. The derivation of Mendelian and Bayesian risk estimates in the setting of well-defined cancer family syndromes, and the growing role of DNA testing in more accurately assessing these risks, are discussed. Such carrier testing requires careful psychologic and ethical considerations.

CONCLUSION

Multidisciplinary cancer genetic counseling is an emerging resource available to physicians who care for families with common adult malignancies.

摘要

目的

由于癌症家族史是一个重要的风险因素,对癌症风险的评估和沟通有助于早期发现和预防工作。本综述为健康专业人员提供了一种资源,这些人员需要借鉴多学科文献,为有癌症家族史的家庭提供定量风险评估。

设计

在癌症遗传咨询的背景下,对基于人群的描述性、流行病学、遗传学、遗传流行病学和分子研究进行了批判性综述。

结果

所呈现的数据记录了乳腺癌、卵巢癌、结肠癌、前列腺癌或其他部位癌症患者的亲属一生中相对风险的增加。一般来说,风险比不太适合临床咨询。给出了乳腺癌、卵巢癌和结肠癌患者一级亲属的年龄特异性绝对风险。讨论了在明确的癌症家族综合征背景下孟德尔和贝叶斯风险估计的推导,以及DNA检测在更准确评估这些风险中日益重要的作用。这种携带者检测需要仔细的心理和伦理考量。

结论

多学科癌症遗传咨询是一种新兴资源,可供照顾患有常见成人恶性肿瘤家庭的医生使用。

相似文献

1
Quantitating familial cancer risk: a resource for clinical oncologists.量化家族性癌症风险:临床肿瘤学家的资源。
J Clin Oncol. 1994 Aug;12(8):1724-36. doi: 10.1200/JCO.1994.12.8.1724.
2
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
3
Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.美国临床肿瘤学会声明:癌症易感性基因检测,1996年2月20日通过。
J Clin Oncol. 1996 May;14(5):1730-6; discussion 1737-40. doi: 10.1200/JCO.1996.14.5.1730.
4
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
5
[Genetic counseling for families at high cancer risk].[针对高癌症风险家庭的遗传咨询]
Harefuah. 1996 Apr 1;130(7):441-6, 504.
6
Cancer incidence in first-degree relatives of a population-based set of cases of early-onset breast cancer.基于人群的早发性乳腺癌病例组一级亲属的癌症发病率。
Eur J Cancer. 2006 Nov;42(17):3034-40. doi: 10.1016/j.ejca.2006.04.025. Epub 2006 Sep 22.
7
Familial risk of breast cancer in a French case-control study.
Cancer Detect Prev. 1994;18(3):163-9.
8
Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.床边的遗传性乳腺癌-卵巢癌:肿瘤内科医生的作用
J Clin Oncol. 2003 Feb 15;21(4):740-53. doi: 10.1200/JCO.2003.05.096.
9
[Genetic counseling in familial breast cancer].
Ther Umsch. 2008 Apr;65(4):235-41. doi: 10.1024/0040-5930.65.4.235.
10
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.特拉华州家族性胰腺癌的全州回顾性研究以及胰腺癌家族中基因突变的频率。
Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4.

引用本文的文献

1
Knowledge, attitude, and perceptions about cancer genetic testing in clinical practice in Karachi, Pakistan.巴基斯坦卡拉奇临床实践中关于癌症基因检测的知识、态度和认知
J Community Genet. 2023 Jun;14(3):337-344. doi: 10.1007/s12687-023-00650-2. Epub 2023 May 5.
2
Cancer Genetic Counseling-Current Practice and Future Challenges.癌症遗传咨询——当前实践与未来挑战。
Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a036541. doi: 10.1101/cshperspect.a036541.
3
Investigation of the Use of a Family Health History Application in Genetic Counseling.
家庭健康史应用程序在遗传咨询中的使用调查。
J Genet Couns. 2018 Apr;27(2):392-405. doi: 10.1007/s10897-017-0196-2. Epub 2017 Dec 22.
4
Complexities in Cancer Risk Counseling: Presentation of Three Cases.癌症风险咨询中的复杂性:三个病例展示
J Genet Couns. 1997 Jun;6(2):147-67. doi: 10.1023/A:1025655917677.
5
Cancer Risk Counseling: How Is It Different?
J Genet Couns. 1997 Jun;6(2):97-109. doi: 10.1023/A:1025699732698.
6
Perspectives on personalized cancer care.个性化癌症护理的观点。
Urol Oncol. 2012 Mar-Apr;30(2):121-5. doi: 10.1016/j.urolonc.2011.01.004.
7
Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.一项基于人群的研究中乳腺癌、结直肠癌、前列腺癌和肺癌家族史的患病率。
Public Health Genomics. 2010;13(7-8):495-503. doi: 10.1159/000294469. Epub 2010 Apr 9.
8
Validity of models for predicting BRCA1 and BRCA2 mutations.预测BRCA1和BRCA2基因突变模型的有效性。
Ann Intern Med. 2007 Oct 2;147(7):441-50. doi: 10.7326/0003-4819-147-7-200710020-00002.
9
PancPRO: risk assessment for individuals with a family history of pancreatic cancer.PancPRO:胰腺癌家族史个体的风险评估
J Clin Oncol. 2007 Apr 10;25(11):1417-22. doi: 10.1200/JCO.2006.09.2452.
10
Prediction of germline mutations and cancer risk in the Lynch syndrome.林奇综合征中生殖系突变及癌症风险的预测
JAMA. 2006 Sep 27;296(12):1479-87. doi: 10.1001/jama.296.12.1479.